ALLO-647
ALLO-647 is a human monoclonal antibody targeting CD52. ALLO-647 transiently and selectively depletes host lymphocytes to promote the proliferation of allogeneic CAR T-cell following infusion. ALLO-647 can be used for the research of B-cell lymphoma and follicular lymphoma.
For research use only. We do not sell to patients.
-
Storage:
Please store the product under the recommended conditions in the Certificate of Analysis.
Biological Activity
Human
ALLO-647 is a human monoclonal antibody targeting CD52, a GPI-anchored low-molecular-weight glycoprotein that is highly expressed on almost all mature T and B cells but not on hematopoietic stem cells. Soluble CD52 is a natural inhibitor of the NF‑κB pathway, which mainly functions in myeloid cells and also exerts cross-regulation in T/B cells.[1]
MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.
CD52
Unconjugated
The product can be reconstituted/diluted with sterile PBS or saline.
-
Product Image
ELISA, FACS, Functional assay
Chemical Information
-
Formulation
Please refer to the lot-specific COA for specific buffer information.
-
Storage
Please store the product under the recommended conditions in the Certificate of Analysis.
Purity & Documentation
References
Calculators
Concentration (start) × Volume (start) = Concentration (final) × Volume (final)